BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24248731)

  • 1. Long-term functional outcome and satisfaction of patients with an active middle ear implant for sensorineural hearing loss compared to a matched population with conventional hearing aids.
    Ihler F; Bewarder J; Blum J; Matthias C; Canis M
    Eur Arch Otorhinolaryngol; 2014 Dec; 271(12):3161-9. PubMed ID: 24248731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Our auditory results using the Vibrant Soundbridge on the long process of the incus: 20 years of data.
    Grégoire A; Van Damme JP; Gilain C; Bihin B; Garin P
    Auris Nasus Larynx; 2018 Feb; 45(1):66-72. PubMed ID: 28285827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Carina active middle-ear implant with conventional hearing aids for mixed hearing loss.
    Savaş VA; Gündüz B; Karamert R; Cevizci R; Düzlü M; Tutar H; Bayazit YA
    J Laryngol Otol; 2016 Apr; 130(4):340-3. PubMed ID: 26991874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active middle ear implant compared with open-fit hearing aid in sloping high-frequency sensorineural hearing loss.
    Boeheim K; Pok SM; Schloegel M; Filzmoser P
    Otol Neurotol; 2010 Apr; 31(3):424-9. PubMed ID: 20042907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Otologics middle ear transducer with contralateral conventional hearing aid in severe sensorineural hearing loss: evolution during the first 24 months.
    Tringali S; Perrot X; Berger P; Granade GL; Dubreuil C; Truy E
    Otol Neurotol; 2010 Jun; 31(4):630-6. PubMed ID: 20418795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esteem® middle ear device versus conventional hearing aids for rehabilitation of bilateral sensorineural hearing loss.
    Monini S; Biagini M; Atturo F; Barbara M
    Eur Arch Otorhinolaryngol; 2013 Jul; 270(7):2027-33. PubMed ID: 23143506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vibrant Sound Bridge System. A new kind hearing prosthesis for patients with sensorineural hearing loss. 2. Audiological results].
    Lenarz T; Weber BP; Issing PR; Gnadeberg D; Ambjørnsen K; Mack KF; Winter M
    Laryngorhinootologie; 2001 Jul; 80(7):370-80. PubMed ID: 11488147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter study of the Vibrant Soundbridge middle ear implant: early clinical results and experience.
    Fraysse B; Lavieille JP; Schmerber S; Enée V; Truy E; Vincent C; Vaneecloo FM; Sterkers O
    Otol Neurotol; 2001 Nov; 22(6):952-61. PubMed ID: 11698825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with the active middle ear implant Vibrant Soundbridge in sensorineural hearing loss.
    Pok SM; Schlögel M; Böheim K
    Adv Otorhinolaryngol; 2010; 69():51-58. PubMed ID: 20610914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient selection for incus body coupling of a totally implantable middle ear implant.
    Zenner HP; Baumann JW; Reischl G; Plinkert P; Zimmermann R; Mauz PS; Limberger A; Maassen MM
    Acta Otolaryngol; 2003 Aug; 123(6):683-96. PubMed ID: 12953766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A middle ear implant, the Symphonix Vibrant Soundbridge: retrospective study of the first 125 patients implanted in France.
    Sterkers O; Boucarra D; Labassi S; Bebear JP; Dubreuil C; Frachet B; Fraysse B; Lavieille JP; Magnan J; Martin C; Truy E; Uziel A; Vaneecloo FM
    Otol Neurotol; 2003 May; 24(3):427-36. PubMed ID: 12806295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esteem 2 middle ear implant: our experience.
    Gerard JM; Thill MP; Chantrain G; Gersdorff M; Deggouj N
    Audiol Neurootol; 2012; 17(4):267-74. PubMed ID: 22627489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ototronix MAXUM middle ear implant for severe high-frequency sensorineural hearing loss: Preliminary results.
    Hunter JB; Carlson ML; Glasscock ME
    Laryngoscope; 2016 Sep; 126(9):2124-7. PubMed ID: 26972428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Middle ear electromagnetic semi-implantable hearing device: results of the phase II SOUNDTEC direct system clinical trial.
    Hough JV; Matthews P; Wood MW; Dyer RK
    Otol Neurotol; 2002 Nov; 23(6):895-903. PubMed ID: 12438853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Totally implantable active middle-ear implants: a large, single-surgeon cohort.
    McCarty Walsh E; Morrison DR; McFeely WJ
    J Laryngol Otol; 2021 Apr; 135(4):304-309. PubMed ID: 33745469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies of active middle ear implants for hearing rehabilitation in congenital aural atresia.
    Verhaert N; Fuchsmann C; Tringali S; Lina-Granade G; Truy E
    Otol Neurotol; 2011 Jun; 32(4):639-45. PubMed ID: 21436753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totally implantable active middle ear implant: Hearing and safety results in a large series.
    Shohet JA; Gende DM; Tanita CS
    Laryngoscope; 2018 Dec; 128(12):2872-2878. PubMed ID: 30194720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantages of binaural hearing provided through bimodal stimulation via a cochlear implant and a conventional hearing aid: a 6-month comparative study.
    Morera C; Manrique M; Ramos A; Garcia-Ibanez L; Cavalle L; Huarte A; Castillo C; Estrada E
    Acta Otolaryngol; 2005 Jun; 125(6):596-606. PubMed ID: 16076708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audiological application criteria for implantable hearing aid devices: a clinical experience at the Nijmegen ORL clinic.
    Verhaegen VJ; Mylanus EA; Cremers CW; Snik AF
    Laryngoscope; 2008 Sep; 118(9):1645-9. PubMed ID: 18677283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with benefit of active middle ear implants compared to conventional hearing aids.
    McRackan TR; Clinkscales WB; Ahlstrom JB; Nguyen SA; Dubno JR
    Laryngoscope; 2018 Sep; 128(9):2133-2138. PubMed ID: 29481695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.